The Tisch Cancer Institute at Mount Sinai is a leader in translating clinical research into cancer immunotherapies for patients. PICI researcher Nina Bhardwaj, MD, PhD, at Mount Sinai is an expert who contributes foundational insights in understanding patient responses to immunotherapy treatments. She closely examines immune behavior to test and develop cancer-curing vaccines. Bhardwaj is instrumental on several PICI research projects and clinical trials, with a focus on prostate and pancreatic cancers. Nina Bhardwaj, MD, PhD | Investigator Related Research Focus Tumor Antigen Discovery: Targeting Cancer Research Project Tumor Neoantigen Selection Alliance (TESLA) Announcement PICI Welcomes New UCSF Center Director Announcement New Staff Members Join PICI Announcement PICI Members and Partners Featured at #CARTCR Announcement, Our Impact PICI Network Researchers Featured at #IO23ASGCT Announcement, Our Impact, Press Release Developing Next-Gen Scientific Leaders Announcement, Our Impact PICI Network Researchers at #ASCO23 Announcement, Partner Highlight Guardant Health, PICI Launch Research Collaboration